market access, reimbursement, and pricing issues for regenerative medicines and atmps
Published 1 year ago • 43 plays • Length 17:34Download video MP4
Download video MP3
Similar videos
-
1:00:25
advance webinar – atmp market access
-
56:40
optimizing market access for medical devices
-
50:32
an introduction to european market access
-
55:47
market access strategies for advanced therapies
-
1:39
how to sell your medtech using market access strategy
-
30:40
key supply chain issues and contracting strategies critical for sponsors of regenerative medicines
-
1:23:16
reimbursement strategies workshop
-
24:28
the transforming health series: where market access meets patient access
-
6:17
market access // prof. lieven annemans about pharmaceutical pricing and risk sharing schemes
-
1:57
market access: pricing
-
59:20
webinar: market access and regulatory update for medical technology (october 2017)
-
57:36
accelerating market access of new medicines
-
42:19
market access for digital therapies and digital medicines
-
3:25
reimbursement, market access strategy, and the importance of a patient access program
-
32:04
keynote lecture 4: market access or patient access? the licensing vs. reimbursement decision process
-
1:04:59
webinar: market access and regulatory update for medical device manufacturers (jul 2016)
-
43:19
firstmedcommsjob: what is market access?
-
10:54
hemogenyx pharmaceuticals explains share consolidation, greenlight for clinical trial